Next Quarterly Earnings
Thursday, October 29, 2026
CW 44
Pre-Market
In 63 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Fate Therapeutics
Fate Therapeutics is a leading U.S.-based biopharmaceutical company specializing in the development of innovative immunotherapies. By leveraging induced pluripotent stem cell (iPSC) technology for cell-based cancer therapies, the company is revolutionizing the treatment of serious medical conditions.
Frequently asked questions
When will Fate Therapeutics report its next quarterly earnings?
Fate Therapeutics is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Fate Therapeutics last report quarterly earnings?
Fate Therapeutics last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -0.25 USD.
How often has Fate Therapeutics beaten expectations?
Fate Therapeutics has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
How do I add the Fate Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
5/5
Quarters above estimates
100%
Beat rate
+1.8%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Fate Therapeutics
Country
🇺🇸
More Financial Information